Suven receives two product patents associated with Neurodegenerative.
MUMBAI: Suven Life Sciences has received two product patents in Eurasia for two new chemical entities for the treatment of disorders associated with Neurodegenerative diseases. These patents are valid until 2023.
The patents are valid in all contracting countries like Armenia, Azerbaijan,
The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neuro-degenarative disorders like Attention deficient hyperactivity, Alzheimer's, Parkinson, Schizophrenia and Huntington's.
The company has six internally-discovered therapeutic drug candidated currently in pre-clinical stage of development targeting conditions such as ADHD, dementia, depression, Huntington's disease. Parkinson's disease and obesity in addition to developmental candidates in Alzheimer's disease and Schizophrenia.
"We are very pleased by the issuance of these patents to Suven for our drug candidates that are being developed for CNS disorders which targets an $18 billion potential market opportunity globally," said Venkat Jasti, CEO of Suven.
Email this Article
Digg It
del.icio.usRelated Articles
- SOMALOGIC GETS RIGHTS TO DNA MODIFICATION PATENTS.
- The FDA, medical foods and patents. (Editorial).
- RayMedica wins two spinal product patents
- Healthcare: simple analysis can ensure product success.
- Patent pleas to be processed faster.
- NUVELO ASSIGNS PATENTS TO SEQUENOM.
- AIR FORCE TO TEST "LIFESHIRT" MONITORING SYSTEMS.
- Uncle Sam can steal your product. (Patents).
- Electronic and software patents; law and practice, 2d ed.; 2006 supplement.
- TWO ARIAD PATENTS ISSUED FOR DRUGS REGULATING GENES.
- Lawyers love dirty e-mails, not murder.
- Dr Reddy's starts diabetes drug's final test.
- Old sectors will again chart course.
- Customs to be armed to take action against IPR violators.
- MNC drugs set to lose mkt monopoly.
SomaLogic, Inc., Boulder, Colo., a privately held proteomics company, has significantly expanded its intellectual property base by acquiring an exclusive license to several key foreign and domestic patents that enable the development of aptamers with enhanced chemical diversity. These DNA ......
More than a year ago, a prominent physician approached me about assisting him in the manufacture of a nutrient product. He questioned whether it should be marketed as a "medical food" or as a "dietary supplement." My response was to ......
A US development-stage company RayMedica Inc is taking further steps towards the commercialisation of its Prosthetic Disc Nucleus (PDN ) with the addition of two patents related to the product that have been allowed. The Bloomington, Minnesota-based company says the ......
The U.S. Patent and Trademark Office issues about 2,000 patents each week on new product ideas, including those introduced to the healthcare market. Unfortunately, less than one-half of 1 percent will ever make it to market. Why? The answer is ......
NEW DELHI: The government on Thursday ushered in a shorter time-frame for processing of patent applications by notifying the Patents (Amendment) Rules of '06. The new rules bring in more transparency, decentralisation of the functioning of patent offices and simplify ......
Nuvelo, Inc. (NASDAQ:NUVO), Sunnyvale, and SEQUENOM, Inc. (NASDAQ:SQNM), San Diego, have signed a patent assignment and license agreement. Under terms of the agreement, Nuvelo assigned SEQUENOM the entire chemical cleavage patent estate acquired through its merger with VARIAGENICS, including 25 ......
The computerized LifeShirt(TM) by VivoMetrics, Inc., based on patents created by Dr. Marvin Sackner and Miami Beach-based Non-Invasive Monitoring Systems, Inc. (NIMS) (OTCBB:NIMU), will be tested by the U.S. Air Force for its capability to monitor armed forces in the ......
The Federal government is able to reach past a patent owner and contract with others to produce the patented product for the government. "Traditionally, patents offer their holders the exclusive right to produce, market, and sell a product," explains Theodore ......
157018612X Electronic and software patents; law and practice, 2d ed.; 2006 supplement. Ed. by Steven W. Lundberg. BNA Books 2006 $185.00 Paperback KF3133 Once again new technologies make for new law, or at......
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA), Cambridge, Mass., has been issued two new U.S. patents covering the discovery of pharmaceuticals that target two critically important families of proteins that regulate the function of human genes. These protein families, collectively known as ......
Byline: Gireesh Chandra Prasad NEW DELHI: Law practice in India is gradually moving from crowded courts to cosy corporate climes. Various streams of corporate commercial practice and arbitration have started eating into the share of litigation, which now accounts for ......
HYDERABAD: The stage has been set for the creation of the country's first intellectual property in the pharma segment with Dr Reddy's and Rheoscience beginning the phase III clinical trials of anti-diabetic drug balagliatzone (DRF-2593). The drug, meant to treat ......
Byline: Pravin Palande MUMBAI: The new year may not see major changes in terms of themes as far as sectors are concerned. Engineering, power, metals will be the themes that will dominate the year. But valuations will be a concern ......
Byline: Deepshikha Sikarwar & G Ganapathy Subramaniam New Delhi: This one is sure to bring cheer to companies, especially MNCs, suffering violation of intellectual property rights (IPR) by imported products. The finance ministry is introducing new norms to curb IPR ......
Byline: Gireesh Chandra Prasad NEW DELHI: The legal battles triggered by the provisional market monopoly granted to Novartis' cancer drug, Glivec, and Eli Lilly's 'entertainment' pill, Cialis, are set to end in favour of their local rivals. Patent lawyers and ......